{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:11:41Z","timestamp":1773292301691,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":2694,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ijid.2005.06.002","type":"journal-article","created":{"date-parts":[[2005,12,23]],"date-time":"2005-12-23T12:14:01Z","timestamp":1135340041000},"page":"93-102","source":"Crossref","is-referenced-by-count":22,"title":["Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates"],"prefix":"10.1016","volume":"10","author":[{"given":"Carlos","family":"Franco-Paredes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Rouphael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"del Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ignacio","family":"Santos-Preciado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2005.06.002_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00000441-200308000-00003","article-title":"Infectious disease, non-zero sum thinking and the developing world","volume":"326","author":"Folch","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ijid.2005.06.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00124743-200202000-00001","article-title":"The ever expanding clinical spectrum of tuberculosis","volume":"8","author":"Franco-Paredes","year":"2002","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.ijid.2005.06.002_bib3","unstructured":"World Health Organization. Issues relating to the use of BCG in immunization programmes. WHO 1999."},{"key":"10.1016\/j.ijid.2005.06.002_bib4","unstructured":"WHO Global Tuberculosis Programme and Global Programme on Vaccines. Statement on BCG revaccination for the prevention of tuberculosis. WHO Wkly Epidemiol Rec 1995;70:229\u201331."},{"key":"10.1016\/j.ijid.2005.06.002_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/79631","article-title":"Is the development of a new tuberculosis vaccine possible?","volume":"6","author":"Kaufmann","year":"2000","journal-title":"Nat Med"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2005.06.002_bib6","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1086\/314063","article-title":"Immunology of bacille Calmette\u2013Gu\u00e9rin and related topics","volume":"31","author":"Wittes","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib7","series-title":"A clinician's guide to tuberculosis","first-page":"399","article-title":"Vaccination to prevent tuberculosis and immunomodulatory therapy for persons with active disease","author":"Iseman","year":"2000"},{"key":"10.1016\/j.ijid.2005.06.002_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette\u2013Gu\u00e9rin vaccination of newborns and infants in the prevention of tuberculosis: meta-analysis of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2005.06.002_bib9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and military tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ijid.2005.06.002_bib10","first-page":"41","article-title":"Tuberculosis control among North American Indians","volume":"45","author":"Townsend","year":"1942","journal-title":"Am Rev Tuberc"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2005.06.002_bib11","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with bacillus Calmette\u2013Gu\u00e9rin Vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ije\/14.3.441","article-title":"A case control study of BCG and childhood tuberculosis in Cali, Colombia","volume":"14","author":"Shapiro","year":"1985","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ijid.2005.06.002_bib13","first-page":"151","article-title":"Prospects for new TB vaccines: Stop TB working group on TB vaccine development","volume":"8","author":"Fruth","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib14","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3201\/eid1009.030921","article-title":"Potential public health impact of new tuberculosis vaccines","volume":"10","author":"Ziv","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2005.06.002_bib16","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1001\/jama.1983.03330410048027","article-title":"The BCG controversy: a methodological and statistical reappraisal","volume":"249","author":"Clemens","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2005.06.002_bib17","first-page":"255","article-title":"Protective vaccination against tuberculosis with special reference to BCG vaccination","volume":"58","author":"Aronson","year":"1948","journal-title":"Am Rev Tuberc"},{"key":"10.1016\/j.ijid.2005.06.002_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0041-3879(49)80055-9","article-title":"BCG vaccination of infant Indians in Saskatchewan","volume":"30","author":"Ferguson","year":"1949","journal-title":"Tubercle"},{"key":"10.1016\/j.ijid.2005.06.002_bib19","first-page":"690","article-title":"BCG vaccination in tuberculous households","volume":"84","author":"Rosenthal","year":"1960","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1542\/peds.28.4.622","article-title":"BCG vaccination against tuberculosis in Chicago: a twenty-year study statistically analyzed","author":"Rosenthal","year":"1961","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2005.06.002_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0041-3879(82)80036-6","article-title":"Pathogenesis of tuberculosis and effectiveness of BCG vaccination","volume":"63","author":"ten Dam","year":"1982","journal-title":"Tubercle"},{"key":"10.1016\/j.ijid.2005.06.002_bib22","first-page":"69","article-title":"Fifteen-year follow-up of the Indian BCG prevention trial","volume":"62","author":"Tripathy","year":"1987","journal-title":"Bull Int Union Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib23","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2005.06.002_bib24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/infdis\/170.2.476","article-title":"Disseminated bacille Calmette\u2013Gu\u00e9rin immunization in normal healthy adults","volume":"170","author":"Talbot","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/bmj.313.7056.528","article-title":"Adverse local reactions from accidental BCG overdose in infants","volume":"313","author":"Puliyel","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2005.06.002_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/338462","article-title":"National study of adverse reactions after vaccination with bacille Calmette\u2013Gu\u00e9rin","volume":"34","author":"Turnbull","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/infdis\/172.2.574","article-title":"Osteitis caused by bacille Calmette\u2013Gu\u00e9rin vaccination: a retrospective analysis of 222 cases","volume":"172","author":"Kr\u00f6ger","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4+ T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijid.2005.06.002_bib29","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.291.17.2127","article-title":"A booster for tuberculosis vaccines","volume":"291","author":"Dye","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2005.06.002_bib30","unstructured":"World Health Organization. BCG Vaccine. Wkly Epidemiol Rec 2004;79:27\u201338."},{"key":"10.1016\/j.ijid.2005.06.002_bib31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.273.5274.497","article-title":"Control strategies for tuberculosis epidemics: new models for old problems","volume":"273","author":"Blower","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ijid.2005.06.002_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/35095558","article-title":"How can immunology contribute to the control of tuberculosis?","volume":"1","author":"Kaufmann","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijid.2005.06.002_bib33","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ijid.2005.06.002_bib34","first-page":"11","article-title":"The case for BCG","volume":"19","author":"Tripathy","year":"1983","journal-title":"Ann Nat Acad Med Sci"},{"key":"10.1016\/j.ijid.2005.06.002_bib35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/infdis\/170.2.476","article-title":"Bacille Calmette\u2013Gu\u00e9rin immunization in normal healthy adults","volume":"170","author":"Brewer","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib36","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/thx.38.11.806","article-title":"BCG: who were Calmette and Gu\u00e9rin?","volume":"38","author":"Sakula","year":"1983","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2005.06.002_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/bmb\/62.1.73","article-title":"Tuberculosis vaccines","volume":"62","author":"Young","year":"2002","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ijid.2005.06.002_bib38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2005.06.002_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0041-3879(36)80249-9","article-title":"Tuberculosis in hospital nurses","volume":"18","author":"Heimbeck","year":"1936","journal-title":"Tubercle"},{"issue":"Suppl","key":"10.1016\/j.ijid.2005.06.002_bib40","first-page":"S70","article-title":"BCG vaccination","volume":"125","author":"Luelmo","year":"1982","journal-title":"Am Rev Resp Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1086\/341901","article-title":"New vaccines for the prevention of tuberculosis","volume":"35","author":"Fordham von Reyn","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib42","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1126\/science.257.5073.1055","article-title":"Tuberculosis: commentary of a reemergent killer","volume":"257","author":"Bloom","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ijid.2005.06.002_bib43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/422319","article-title":"Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands","volume":"39","author":"Haverkamp","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1086\/422326","article-title":"Nontuberculous mycobacteria: clinical importance and relevance to bacille Calmette\u2013Gu\u00e9rin vaccination","volume":"39","author":"Valadas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0041-3879(87)90070-5","article-title":"Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood","volume":"68","author":"Katila","year":"1987","journal-title":"Tubercle"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2005.06.002_bib46","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1086\/314071","article-title":"Animal models in experimental tuberculosis","volume":"31","author":"Smith","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib47","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nm868","article-title":"Building a better tuberculosis vaccine","volume":"9","author":"Young","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2005.06.002_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S002217240006945X","article-title":"BCG vaccination of children against leprosy in Uganda: final results","volume":"87","author":"Stanley","year":"1981","journal-title":"J Hyg (Camb)"},{"key":"10.1016\/j.ijid.2005.06.002_bib49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0140-6736(92)90794-4","article-title":"Efficacy of BCG against leprosy and tuberculosis in Northern Malawi","volume":"339","author":"Ponnighaus","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2005.06.002_bib50","doi-asserted-by":"crossref","unstructured":"Karonga Prevention Trial Group. Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 1996;348:17\u201324.","DOI":"10.1016\/S0140-6736(96)02166-6"},{"key":"10.1016\/j.ijid.2005.06.002_bib51","first-page":"542","article-title":"Case control study of BCG vaccination as a risk factor for leprosy and tuberculosis in Western Kenya","volume":"61","author":"Orege","year":"1993","journal-title":"Int J Lepr"},{"issue":"Suppl","key":"10.1016\/j.ijid.2005.06.002_bib52","first-page":"S44","article-title":"Primary prevention of leprosy","volume":"64","author":"Fine","year":"1996","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib53","unstructured":"Leprosy Prevention Trial Madras (Abstract). BCG prophylaxis for leprosy in South India. Int J Lepr Other Mycobact Dis 1998;66 (Suppl):99A."},{"key":"10.1016\/j.ijid.2005.06.002_bib54","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0035-9203(76)90128-0","article-title":"The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda","volume":"70","author":"Smith","year":"1976","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2005.06.002_bib55","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0962-8479(94)90080-9","article-title":"Six years\u2019 experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against Mycobacterium avium intracellulare complex","volume":"75","author":"Trnka","year":"1994","journal-title":"Tuber Lung Disease"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2005.06.002_bib56","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/314075","article-title":"What does tuberculin reactivity after bacille Calmette\u2013Gu\u00e9rin vaccination tell us?","volume":"31","author":"Menzies","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1086\/426434","article-title":"Influence of bacille Calmette\u2013Gu\u00e9rin vaccination on size of tuberculin skin test reaction: to what size?","volume":"40","author":"Tissot","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib58","first-page":"624","article-title":"Quantifying the intrinsic transmission dynamics of tuberculosis","volume":"76","author":"Porco","year":"1998","journal-title":"Theor Popul Biol"},{"key":"10.1016\/j.ijid.2005.06.002_bib59","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2005.06.002_bib60","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.285.5.606","article-title":"Prospects for vaccines to protect against AIDS, tuberculosis, and malaria","volume":"285","author":"Letvin","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2005.06.002_bib61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1472-9792(02)00080-X","article-title":"Prospects for a better vaccine against tuberculosis","volume":"83","author":"Reed","year":"2003","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.ijid.2005.06.002_bib62","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00063198-200205000-00006","article-title":"Tuberculosis and vaccine development","volume":"8","author":"Doherty","year":"2002","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ijid.2005.06.002_bib63","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.4049\/jimmunol.161.10.5284","article-title":"Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis","volume":"161","author":"Waldrop","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2005.06.002_bib64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jim.2004.06.010","article-title":"Novel application of whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies","volume":"291","author":"Hanekom","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ijid.2005.06.002_bib65","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1128\/IAI.72.11.6401-6407.2004","article-title":"Novel human in vitro system for evaluating antimycobacterial vaccines","volume":"72","author":"Kampmann","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijid.2005.06.002_bib66","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/IAI.65.5.1856-1862.1997","article-title":"Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae","volume":"65","author":"Abou-Zeid","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijid.2005.06.002_bib67","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","article-title":"Prime-boost immunization strategies for tuberculosis","volume":"7","author":"McShane","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.ijid.2005.06.002_bib68","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nature Med"},{"key":"10.1016\/j.ijid.2005.06.002_bib69","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","article-title":"Protection of mice with a tuberculous subunit vaccine based on a fusion protein of Ag85B and ESAT-6","volume":"69","author":"Olsen","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijid.2005.06.002_bib70","first-page":"1042","article-title":"Vaccines and vaccination","author":"Gordon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2005.06.002_bib71","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nm0896-888","article-title":"Vaccination against tuberculosis by DNA injection","volume":"2","author":"Tascon","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2005.06.002_bib72","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1128\/IAI.68.6.3674-3679.2000","article-title":"Lack of protection in mice with necrotizing bronchointerstitial pneumonia with bronchiolitis in guinea pigs immunized with vaccines directed against the hsp60 molecule of Mycobacterium tuberculosis","volume":"68","author":"Turner","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijid.2005.06.002_bib73","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine","volume":"2","author":"Huygen","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2005.06.002_bib74","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDA major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijid.2005.06.002_bib75","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomized controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2005.06.002_bib76","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1128\/IAI.65.11.4525-4530.1997","article-title":"Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis","volume":"65","author":"Skinner","year":"1997","journal-title":"Infect Immun"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2005.06.002_bib77","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1086\/313880","article-title":"Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis","volume":"30","author":"Waddell","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib78","first-page":"S11","article-title":"Immunogenicity of a multiple dose series of an inactivated vaccine for the prevention of tuberculosis in HIV infection: a blinded controlled trial","volume":"5","author":"von Reyn","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2005.06.002_bib79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMp048319","article-title":"Achieving the millennium development goals \u2013 the case of malaria","volume":"352","author":"Sachs","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2005.06.002_bib80","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tube.2004.09.015","article-title":"Boosting BCG with MV A85A: the first candidate subunit vaccine for tuberculosis in clinical trials","volume":"85","author":"McShane","year":"2005","journal-title":"Tuberculosis (Edinb)"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971205001669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971205001669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:28:10Z","timestamp":1683332890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971205001669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1201971205001669"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2005.06.002","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}